Phoenix 24
A proposed EU response links women’s health with economic equality.
BRUSSELS
European trade unions are calling for menopause to be explicitly recognized in European Union workplace legislation, arguing that inadequate support is affecting women’s earnings, professional advancement and retirement security. The proposal comes as European institutions reconsider whether existing employment protections sufficiently address health conditions that can influence women’s working lives.
The European Trade Union Confederation, representing approximately 45 million members across 41 European countries, wants employers to assess menopause-related workplace risks and introduce practical adjustments. Its campaign coincides with World Menopause Day and growing debate over the economic consequences of women’s health inequalities.
Menopause typically occurs between ages 45 and 55, although individual experiences vary considerably. Symptoms may include sleep disruption, hot flashes, fatigue, joint discomfort, anxiety and difficulties concentrating. Some women experience limited disruption, while others encounter symptoms that substantially affect everyday activities and professional responsibilities.
Figures cited by the confederation suggest that approximately 85% of women experience at least one symptom, while around 30% report effects that interfere with their ability to work. These estimates describe different dimensions of menopause and should not be interpreted as evidence that every affected woman requires the same accommodation.
The economic consequences can extend beyond immediate discomfort. Research cited by the unions found that earnings among women in Norway declined by 7.4% in the fourth year following a menopause diagnosis. Reduced working hours, sickness absence and missed professional opportunities were among the factors associated with this change.
Such findings raise questions about how workplace conditions interact with health and career progression. They do not establish that menopause alone explains every observed difference in earnings, but they suggest that inadequate organizational responses may contribute to existing employment inequalities.
The confederation is requesting measures including flexible schedules, remote-work options, improved ventilation, temperature controls and ergonomic adjustments. It also advocates paid leave for significant symptoms, training for managers and policies negotiated through collective bargaining.
These proposals reflect a broader occupational health principle: workplace conditions can influence how individuals experience and manage medical symptoms. A physically demanding environment, inflexible attendance requirements or limited access to appropriate facilities may create difficulties that relatively modest adjustments could reduce.
The political question is whether these adaptations should remain voluntary employer practices or become part of a coordinated European legal framework.
The European Commission has not proposed dedicated menopause legislation. Although it incorporated the issue into its Gender Equality Strategy 2026-2030, the current approach emphasizes exchanging national practices and conducting further research rather than establishing specific workplace entitlements.
A study planned for 2028 will examine the economic and social benefits of reducing gaps in women’s health, including those associated with menopause. This represents institutional recognition of the issue, but not an adopted legal obligation requiring employers throughout the EU to provide particular accommodations.
The European Parliament is considering a more ambitious approach. Spanish Socialist lawmaker Lina Gálvez is leading a draft report that frames menopause as an economic, employment and social concern rather than solely a medical matter.
The parliamentary initiative calls for stronger research, public education, improved healthcare access and workplace support. It remains under discussion and should not be confused with legislation already approved by the European Union.
The debate also raises practical questions about implementation. Occupational accommodations must account for differences between jobs, individual symptoms and operational requirements. Policies designed without appropriate confidentiality protections could unintentionally expose employees to stigma or pressure to disclose private medical information.
A broader concern involves the treatment of menopause as a uniform experience. Effective measures may require individual assessment rather than assumptions about age, performance or professional capacity. Protecting employees should not become another mechanism for questioning their competence or limiting advancement.
For employers, the discussion extends beyond compliance. Retaining experienced personnel, reducing avoidable absences and maintaining inclusive working conditions have potential organizational benefits, although their economic effects require careful evaluation.
The European initiative illustrates a gradual shift in how occupational health is understood. Workplace equality depends not only on formal access to employment but also on whether organizational conditions accommodate relevant differences in workers’ health needs.
The central question remains unresolved: whether European institutions will translate growing recognition of menopause into enforceable protections, and how those protections could be implemented without reinforcing the very inequalities they seek to address.
Beyond the Headlines, Accountability Matters.